| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/23/2011 | US20110150910 Methods of inducing an immune response |
| 06/23/2011 | US20110150897 Influenza targets |
| 06/23/2011 | US20110150889 Haemophilus influenzae type iv pili |
| 06/23/2011 | US20110150883 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/23/2011 | US20110150882 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 06/23/2011 | US20110150881 Inhibitors of extracellular hsp90 |
| 06/23/2011 | US20110150877 Ephrin-b receptor protein involved in carcinoma |
| 06/23/2011 | US20110150876 Prognosis and Treatment of Breast Cancer |
| 06/23/2011 | US20110150868 Diagnostic and therapeutic methods and compositions involving pten and breast cancer |
| 06/23/2011 | US20110150866 Compositions and Methods for Increasing Bone Mineralization |
| 06/23/2011 | US20110150863 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 06/23/2011 | US20110150859 method for selecting responders to blockade of integrin receptors |
| 06/23/2011 | US20110150845 Methods and compositions for modulating immunological tolerance |
| 06/23/2011 | US20110150780 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 06/23/2011 | US20110150775 Genomic approaches to fetal treatment and diagnosis |
| 06/23/2011 | US20110150774 Screening for modulators of ces1 and/or ces3 for the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 06/23/2011 | US20110150773 Modulators of acetyl-coenzyme a acyltransferase 1 or 2 in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 06/23/2011 | US20110150772 Modulators of carnitine octanoyltransferase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 06/23/2011 | US20110150771 Chimeric west nile/dengue viruses |
| 06/23/2011 | US20110150765 Frozen compositions and methods for piercing a substrate |
| 06/23/2011 | US20110150760 PRLR-Specific Antibody and Uses Thereof |
| 06/23/2011 | US20110150758 Tracking of bone marrow cells for metastasis screening |
| 06/23/2011 | US20110149287 Semen analysis |
| 06/23/2011 | US20110147591 Semen analysis |
| 06/23/2011 | US20110147234 Biosensor, thin film electrode forming method, quantification apparatus, and quantification method |
| 06/23/2011 | CA2784837A1 Method for analyzing rna |
| 06/23/2011 | CA2784613A1 Diagnostic methods based on somatically acquired rearrangement |
| 06/23/2011 | CA2784500A1 Anti-thrombosis aptamers and method for stabilizing the structure thereof |
| 06/23/2011 | CA2784495A1 Analysis of amino acids and amine-containing compounds using tagging reagents and lc-ms workflow |
| 06/23/2011 | CA2784474A1 Microbial assay |
| 06/23/2011 | CA2784252A1 Dicer substrate agents and methods for the specific inhibition of gene expression |
| 06/23/2011 | CA2784143A1 Systems for managing drug delivery devices |
| 06/23/2011 | CA2783693A1 Markers and method for the diagnosis of rosacea |
| 06/23/2011 | CA2783549A1 Improved bulked mutant analysis |
| 06/23/2011 | CA2783548A1 Restriction enzyme based whole genome sequencing |
| 06/23/2011 | CA2782943A1 Detecting the decomposition of enzymes in a test element by means of controlled release of protected analyte |
| 06/22/2011 | EP2336780A1 Genes and polypeptides relating to prostate cancers |
| 06/22/2011 | EP2336779A1 Identification of cancer protein biomarkers using proteomic techniques |
| 06/22/2011 | EP2336775A2 High affinity TCR proteins and methods |
| 06/22/2011 | EP2336768A1 Method for assaying protein-protein interaction |
| 06/22/2011 | EP2336370A2 Recombinant Newcastle disease virus RNA expression systems and vaccines |
| 06/22/2011 | EP2336369A1 Probes for genotyping low-risk-HPV |
| 06/22/2011 | EP2336368A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/22/2011 | EP2336367A1 Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1 |
| 06/22/2011 | EP2336366A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 06/22/2011 | EP2336365A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 06/22/2011 | EP2336364A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 06/22/2011 | EP2336363A1 MicroRNAs and uses thereof |
| 06/22/2011 | EP2336362A1 Use of CRISPR associated genes (cas) |
| 06/22/2011 | EP2336361A2 Kit for recombinase polymerase amplification |
| 06/22/2011 | EP2336360A1 Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin K epoxide reductase gene and warfarin dosage |
| 06/22/2011 | EP2336359A1 1L1RL-1 as a cardiovascular disease marker and therapeutic target |
| 06/22/2011 | EP2336358A1 Simultaneous detection of multiple nucleic acid sequences in a reaction |
| 06/22/2011 | EP2336356A1 Method for prognosis of a septic syndrome |
| 06/22/2011 | EP2336355A1 Biological rhythm prediction method |
| 06/22/2011 | EP2336354A1 A method for the detection of a RNA molecule, a kit and a use related thereof |
| 06/22/2011 | EP2336353A1 miRNA fingerprints in the diagnosis of diseases |
| 06/22/2011 | EP2336352A1 Biosensor for detecting anti-hiv antibodies |
| 06/22/2011 | EP2336351A2 Method of selectively determining glycated hemoglobin |
| 06/22/2011 | EP2336350A1 Combination of reader and incubator |
| 06/22/2011 | EP2336349A1 Rapid procedure for detection of microorganisms with magnetic particles |
| 06/22/2011 | EP2336348A1 Cell detection method, and microarray chip for use in the method |
| 06/22/2011 | EP2336330A2 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
| 06/22/2011 | EP2336322A1 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 06/22/2011 | EP2336316A1 Method of diagnosing small cell lung cancer |
| 06/22/2011 | EP2336312A1 Triterpene oxidase derived from glychyrrhiza plant, gene encoding the oxidase, and method for utilizing the gene |
| 06/22/2011 | EP2336302A1 Nucleotide sequence encoding the enzyme I-sceI and the uses thereof |
| 06/22/2011 | EP2336297A2 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/22/2011 | EP2336185A1 Anti- alpha v beta 6 antibodies |
| 06/22/2011 | EP2336173A1 Antibody capable of binding to envelope protein 2 of hepatitis c virus, and method for identifying genotype of hepatitis c virus using same |
| 06/22/2011 | EP2336169A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 06/22/2011 | EP2336168A1 Novel protein and method for producing the protein |
| 06/22/2011 | EP2336167A1 MHC molecule constructs and their uses for diagnosis and therapy |
| 06/22/2011 | EP2336166A1 Compositions that inhibit proliferation of cancer cells |
| 06/22/2011 | EP2336157A2 Gene products which are differentially expressed in tumours and use thereof |
| 06/22/2011 | EP2336156A2 Gene products which are differentially expressed in tumours and use thereof |
| 06/22/2011 | EP2336151A1 Replikin peptides and uses thereof |
| 06/22/2011 | EP2336150A2 Replikin peptides and uses thereof |
| 06/22/2011 | EP2336134A1 Fitness assay and methods for reducing resistance of HIV to therapy |
| 06/22/2011 | EP2335693A2 Therapeutic use of nitric oxide precursor |
| 06/22/2011 | EP2335566A1 Compound metal analyte sensor |
| 06/22/2011 | EP2335075A1 Methods for the detection of circulating tumor cells |
| 06/22/2011 | EP2335072A2 Method and device for combined detection of viral and bacterial infections |
| 06/22/2011 | EP2335069A2 A method of detecting antibodies and antibody-hiv virion complexes |
| 06/22/2011 | EP2335067A1 Sample measurement system |
| 06/22/2011 | EP2335066A2 Methods for identification and prediction of multiple sclerosis disease and therapy response |
| 06/22/2011 | EP2335048A1 Method and apparatus for detecting undesired measurement conditions |
| 06/22/2011 | EP2334845A2 Functional layers of biomolecules and living cells, and a novel system to produce such |
| 06/22/2011 | EP2334827A1 Method for chromogenic detection of two or more target molecules in a single sample |
| 06/22/2011 | EP2334826A2 Method of detection and diagnosis of oral and nasopharyngeal cancers |
| 06/22/2011 | EP2334825A1 Method for detecting the differential expression of a set of molecular markers associated with parkinson s disease |
| 06/22/2011 | EP2334824A2 A method of estimating sepsis risk in an individual with infection |
| 06/22/2011 | EP2334823A1 Methods and compositions for diagnosing and treating a colorectal adenocarcinoma |
| 06/22/2011 | EP2334822A2 Method for lowering the dependency towards sequence variation of a nucleic acid target in a diagnostic hybridization assay |
| 06/22/2011 | EP2334821A2 Means and methods for diagnosing predisposition for treatment emergent suicidal ideation (tesi) |
| 06/22/2011 | EP2334820A1 Genetic variants useful for risk assessment of thyroid cancer |
| 06/22/2011 | EP2334819A2 Transcription factor decoys |
| 06/22/2011 | EP2334818A2 Method for the prognosis and diagnosis of type ii diabetes in critical persons |
| 06/22/2011 | EP2334817A1 Analysis of the size of nucleic acids |
| 06/22/2011 | EP2334816A1 Genes associated with posttraumatic-stress disorder (ptsd) |